What question did this study set out to answer?

The study aims to analyze drug recalls in Spain and assess their potential impact on supply continuity and public health.

Drug Recalls in Spain: A 14-year Retrospective Regulatory Analysis in Spain

View Full Paper

Ask AI

Bookmark

Authors

This retrospective analysis reveals significant drug recalls and their impact on supply continuity in Spain, highlighting public health risks.

The study aims to analyze drug recalls in Spain and assess their potential impact on supply continuity and public health.
Conducted a descriptive retrospective analysis of drug recalls from 2010 to 2023.
Utilized data from the Spanish Agency of Medicines and Medical Devices (AEMPS).
Cross-referenced recalls from 2020 to 2023 with national shortage records to evaluate supply impact.
Identified 1,120 drug recalls, with 87.86% involving prescriptions and 57.32% classified as Class 2 recalls.
Nitrosamines were the primary cause, accounting for 22.50% of recalls, with a peak in 2018.
195 recalls from 2020 to 2023 resulted in 55 drug shortages, of which 10.91% had a high clinical impact.

Ruiz et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

This retrospective analysis reveals significant drug recalls and their impact on supply continuity in Spain, highlighting public health risks.